Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Climb Global CLMB Risk Reward Ratio Q4 2025 Profit Exceeds Views US Bancorp USB CFO Insights Survey Reveals Strategic Pivot Toward Growth Amid Persistent Cost Discipline and Rising Geopolitical Concerns Is Gladstone LANDP stock underpriced in the market Slight Downtick 20260418 REX REX Stock Bid Wall 222 20260420 Why are smart money investors paying attention to Otter Tail OTTR Smart Money Active 20260511 UnitedHealth Group Inc UNH AI Investment Push Upside Guidance and Strategic Repositioning Drive 7 Intraday Rally OPK OPKO Health Q4 2025 EPS outpaces estimates by 42 percent stock ticks higher today Kevin Warshs Preferred Inflation Gauge Faces Skepticism What It Means for Fed Policy Cautiously Optimistic on India as Earnings Revival Takes Center Stage Says Geosphere Capitals Arvind Sanger Energy Markets Show Caution as Crude Oil Approaches Key Resistance Zone Is ApexTreasury APXT Undervalued at 1000 20260514 Rigetti RGTIW Falls 1045 Watching 680 Support 20260518 KRAKacquisition KRAQ Unchanged at 992 RangeBound Trading 20260515 Monetarism Under Fire Critics Draw Parallels to Soviet Central Planning Singapore Regulator Seeks Faster Onboarding for Private Banking Clients Fed RateCut Prospects Hinge on Upcoming Jobs Data as Policy Window Narrows TD Cowen and RBC Capital Markets Adjust Home Depot Price Targets Following Solid Q1 Execution Bernstein Maintains Outperform Rating on UnitedHealth as PBM Transparency Initiative Unfolds Signos Secures 20M Funding Expands Dexcom Partnership Amid GLP1 Weight Loss Trend LGND Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Strength FB Financial Q1 2026 Earnings Slight EPS Miss Meets Modest Stock Gains MTB Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher Newmont Q1 2026 Earnings Strong EPS Beat Driven by Robust Gold Production and Cost Discipline GROV Q1 2026 Earnings Significant EPS Beat Surprises Market DFTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Reports WiderThanExpected Loss Quad Graphics QUAD Gains 18 as Stock Approaches Key Resistance Level Neumora Therapeutics NMRA Edges Lower as Stock Tests Key Support at 175 Surrozen Inc SRZN Holds Steady Near Support as Consolidation Continues China Natural Resources Inc CHNR Slips 31 as Selling Pressure Tests Key Support Zone NeoGenomics Inc NEO Edges Higher as Stock Hovers Near Support in a Consolidative Phase